West Virginia becomes the first state to lower patient costs by sharing the savings
By Scott LaGanga | April 20, 2021
In a historic moment for patient affordability, last week West Virginia became the first state in the nation to adopt ground-breaking legislation, HB2263, requiring insurers and their PBMs to...
Read More
Top five issues voters want addressed in the administration’s first 100 days
By Mark Keida | February 18, 2021
When voters cast their ballots in the 2020 election, they made clear their focus on getting COVID-19 under control and fixing the economy. However, health care was still important to many voters,...
Read More
Insurers shift medicine costs to patients with severe chronic illnesses
By Gabby Migliara | February 1, 2021
For many patients with complex and chronic conditions, high out-of-pocket costs for medicines pose a significant challenge. Recent research revealed a broken insurance system that fails to help...
Read More
Accumulator adjustment programs lead to surprise out-of-pocket costs and nonadherence, analysis finds
By Gabby Migliara | November 19, 2020
A new analysis by IQVIA looked at three cost-sharing assistance programs and found that from 2018 to 2020, 25% to 36% of patients discontinued treatment when they faced an unexpectedly high...
Read More
Survey found insurance premiums grew faster than inflation in 2020
By Gabby Migliara | October 20, 2020
According to Kaiser Family Foundation’s recent survey on employer health benefits, premiums for people with employer-sponsored health insurance increased by 4% last year, faster than both the rate...
Read More
Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually
By Gabby Migliara | August 19, 2020
A recent analysis by IQVIA shows that chronically ill patients who used manufacturer cost-sharing assistance in 2019 saved hundreds to thousands of dollars on their out-of-pocket costs. IQVIA...
Read More
Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
By Gabby Migliara | August 12, 2020
According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of...
Read More
Commercial health plans’ transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs for brand medicines
By Gabby Migliara | August 6, 2020
A decade ago, most patients paid only copays for brand medicines. But in recent years, use of deductibles and coinsurance in commercial health plans has skyrocketed. According to a recent IQVIA...
Read More
Four things to know about the IQVIA “Medicine Spending and Affordability in the U.S.” report
By Katie Koziara | August 5, 2020
Today, IQVIA released a new report, Medicine Spending and Affordability in the U.S., providing context on medicine price and spending trends and patient out-of-pocket costs. The report highlights...
Read More
New data show commercially insured patients face increasingly high cost sharing for brand medicines
By Gabby Migliara | July 30, 2020
New data show deductibles and coinsurance result in high out-of-pocket spending for commercially insured patients taking brand medicines. IQVIA analyzed trends in cost sharing across seven therapy...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
